查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球營養補充食品市場：按產品來源、製備、功能、最終產品、配方、功能應用、地區 - 預測至 2028 年
市場調查報告書
商品編碼
1408627

全球營養補充食品市場：按產品來源、製備、功能、最終產品、配方、功能應用、地區 - 預測至 2028 年

Nutraceutical Excipients Market by Product Source (Organic Chemicals, Inorganic Chemicals), Functionality (Binders, Colorants, Flavors & Sweeteners), End Product, Formulation, Functionality Application and Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 379 Pages | 訂單完成後即時交付

價格
簡介目錄
調查範圍
調查年份 2023-2028
基準年 2022年
預測期 2023-2028
目標單位 金額（美元）、數量（千噸）
按細分市場 按功能性別、按產品來源、按製備、依功能用途、依最終產品、按地區
目標區域 北美、南美、歐洲、亞太地區、世界其他地區

2023年全球營養補充食品市場規模達42億美元。

到 2028 年，該市場預計將達到 61 億美元，預測期內複合年成長率為 7.7%。營養補充食品的客製化正在興起，以滿足獨特的配方需求。公司正在創新創造適合各種應用的添加劑，使製造商能夠創造出食品各種消費者需求的營養補充。添加劑技術的不斷進步正在推動具有特定功能要求的專用添加劑的開發。市場需求集中在具有增強溶解度、改善掩味、控制釋放和優異吸收率的添加劑，從而推動市場擴張。

補充食品補充品市場正呈現日益成長的個人化趨勢，消費者尋求符合其個人健康需求和偏好的客製化產品。個體化營養補充的日益成長的趨勢正在推動對可適應特定製劑的客製化添加劑的食品。這種客製化添加劑對於配方奶粉製造商生產多功能補充品和機能性食品至關重要，可提供給藥、釋放機制和有針對性的營養輸送方面的彈性。這些添加劑能夠開發出精確客製化的產品，以解決獨特的健康問題或符合消費者的偏好，從而提高最終產品的有效性和吸引力。這種向個人化的演變凸顯了客製化健康解決方案在營養補充食品的重要性，並反映了挑剔的消費者對個體化健康方法的渴望。

營養補充食品功能類別中的粘合劑部分因其在控制錠劑溶出特性方面的關鍵作用而成為第二大部分。這種控制會影響錠劑在消化道內分散和輸送活性成分的方式，直接影響營養補充食品的生物利用度和有效性。配方中粘合劑的多功能性允許生產具有不同釋放曲線的錠劑，包括即時釋放和持續釋放，並適應多種活性成分。此外，粘合劑對錠劑的穩定性有顯著貢獻，透過防止過早崩壞和破損來確保錠劑的結構完整性。

緩釋添加劑在緩釋性食品市場營養補充的主導地位是由於它們能夠複雜地控制營養補充食品中活性成分的釋放。這種控制有利於客製化釋放曲線，包括緩釋性、延遲或定向釋放，從而確保體內營養物質的受控和一致輸送。此外，這些添加劑透過協調活性成分的受控和高效釋放來最佳化營養物質的生物利用度，最終增加體內營養物質的吸收和利用。其促進活性食品持續穩定釋放的作用極大地有助於提高營養補充的功效。這種持續輸送可以維持體內最佳的營養水平，促進卓越的健康結果，並鞏固其作為營養補充食品功能應用類別中最重要部分的地位。

歐洲日益成長的健康意識正在推動對提供精確健康益處的機能性食品和營養補充的需求不斷成長。由於歐洲人口中很大一部分年齡超過 50 歲，並且容易患慢性病，因此人們對食品預防和治療目的的營養補充越來越感興趣。研究和開發的不斷進步導致了創新添加劑的出現，這些添加劑具有增強的功能、增強的生物利用度和有針對性的營養輸送。這些進步提高了營養補充的有效性和食品消費者的吸引力。此外，營養補充食品市場的個人化趨勢正在加劇。消費者正在積極尋求適合其特定需求和偏好的產品，從而推動了對可適應個別配方的可客製化添加劑的需求不斷成長。

本報告調查了全球營養補充食品市場，並總結了產品原產地、配方、功能、最終產品、配方、功能應用、區域趨勢以及進入市場的公司概況等資訊。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 總體經濟指標
  • 市場動態

第6章 產業趨勢

  • 介紹
  • 價值鏈分析
  • 影響客戶業務的趨勢/干擾
  • 技術分析
  • 價格分析
  • 專利分析
  • 生態系/市場地圖
  • 貿易場景
  • 2023-2024年重大會議和活動
  • 關稅和監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準
  • 案例研究分析

第7章營養補充食品添加劑市場，依產品來源

  • 介紹
  • 有機化學品
  • 無機化學品
  • 其他

第8章營養補充食品添加劑市場（按最終產品）

  • 介紹
  • 益生菌
  • 益生元
  • 蛋白質和胺基酸
  • 維他命
  • 礦物
  • Omega-3脂肪酸
  • 其他

第9章營養補充食品添加劑市場，按製備

  • 介紹
  • 乾燥
  • 液體
  • 其他

第10章營養補充食品添加劑市場，功能性細分市場

  • 介紹
  • 粘合劑
  • 填充劑和稀釋劑
  • 崩壞
  • 被覆劑
  • 調味劑和甜味劑
  • 防腐劑
  • 潤滑劑和助流劑
  • 懸浮劑和增稠劑
  • 著色劑
  • 乳化劑
  • 其他

第11章營養補充食品添加劑市場（按應用）

  • 介紹
  • 掩味
  • 穩定化
  • 修改版本
  • 提高溶解度和生物利用度
  • 其他

第12章營養補充食品添加劑市場（按地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 其他地區

第13章競爭形勢

  • 概述
  • 市場佔有率分析
  • 主要參與企業的策略/秘密
  • 收益分析
  • 主要企業年收益與成長
  • 主要企業EBIT/EBITDA
  • 主要市場參與企業的全球概況
  • 企業評價矩陣（主要企業）
  • Start-Ups/小型企業評估矩陣
  • 競爭場景

第14章 公司簡介

  • 主要參與企業
    • INTERNATIONAL FLAVORS & FRAGRANCES INC
    • KERRY GROUP PLC
    • INGREDION
    • SENSIENT TECHNOLOGIES CORPORATION
    • ASSOCIATED BRITISH FOODS PLC
    • BASF SE
    • ROQUETTE FRERES
    • MEGGLE GROUP GMBH
    • CARGILL, INCORPORATED
    • ASHLAND
    • AZELIS GROUP
    • IMCD
    • HILMAR CHEESE COMPANY, INC.
    • SEPPIC
    • BIOGRUND GMBH
  • 其他公司
    • INNOPHOS
    • DAICEL CORPORATION
    • ALSIANO A/S
    • JRS PHARMA
    • COLORCON
    • PANCHAMRUT CHEMICALS
    • OMYA
    • GATTEFOSSE
    • FUJI CHEMICAL INDUSTRIES CO., LTD
    • JIGS CHEMICAL

第15章 鄰近及相關市場

第16章附錄

簡介目錄
Product Code: FB 6004

Report Description

Scope of the Report
Years Considered for the Study2023-2028
Base Year2022
Forecast Period2023-2028
Units ConsideredValue (USD), volume (KT)
SegmentsBy Functionality, Product Source, Formulation, Functionality Application, End Product, and Region
Regions coveredNorth America, South America, Europe, Asia Pacific, and RoW

The global market for nutraceutical excipients is estimated at USD 4.2 billion in 2023 and is projected to reach USD 6.1 billion by 2028, at a CAGR of 7.7% during the forecast period. Customization of nutraceutical excipients is on the rise, meeting unique formulation needs. Companies are innovating, creating excipients suited for varied applications, enabling manufacturers to craft tailored nutraceuticals for diverse consumer requirements. Continuous advancements in excipient technologies are facilitating the development of specialized excipients, sought after for specific functionalities. The market demand focuses on excipients with enhanced solubility, improved taste-masking, controlled release, and superior absorption rates, fueling market expansion.

"The growing trend of personalization will propel the nutraceutical excipients market forward."

The nutraceutical market is witnessing a surge in the trend of personalization, wherein consumers increasingly seek tailored products aligning with their individual health needs and preferences. This growing inclination towards personalized nutraceuticals has spurred a demand for customized excipients capable of adapting to specific formulations. These tailored excipients are pivotal in allowing formulators to create versatile supplements or functional foods, offering flexibility in dosage, release mechanisms, and targeted nutrient delivery. They enable the development of products precisely tailored to address unique health concerns or align with the preferences of consumers, thereby elevating the effectiveness and attractiveness of the final product. This evolution towards personalization underscores the importance of customized health solutions in the nutraceutical industry, reflecting the desire for individualized wellness approaches among discerning consumers.

"In 2022, binders stood as the second-largest segment within the by functionality of nutraceutical excipients. "

The segment of binders in the functionality category of nutraceutical excipients emerges as the second largest due to its pivotal role in controlling the tablet's dissolution properties. This control influences how the tablet disperses and delivers active ingredients within the digestive system, directly impacting the bioavailability and efficacy of the nutraceutical product. Binders' versatile nature in formulations allows for crafting tablets with varying release profiles, be it immediate or sustained release, accommodating a diverse range of active ingredients. Additionally, binders significantly contribute to tablet stability, preventing premature disintegration or breakage, thereby ensuring the tablet's structural integrity, a critical factor influencing its shelf life and effectiveness.

"Within the functionality application segment, modified-release segment holds the most substantial share."

The leading position of modified-release excipients in the functionality application segment of the nutraceutical excipients market is attributed to their ability to intricately regulate the release of active ingredients within nutraceutical formulations. This control facilitates customized release profiles, encompassing sustained, delayed, or targeted release, thereby ensuring a controlled and consistent nutrient delivery in the body. Furthermore, these excipients optimize the bioavailability of nutrients by orchestrating a controlled and efficient release of active ingredients, ultimately enhancing the body's absorption and utilization of nutrients. Their role in facilitating a sustained and steady release of active ingredients significantly contributes to bolstering the effectiveness of nutraceuticals. This sustained delivery maintains optimal nutrient levels in the body, promoting superior health outcomes and solidifying their position as the foremost segment within the functionality application category of nutraceutical excipients.

"The nutraceutical excipients market in Europe is anticipated to maintain consistent growth throughout the forecast period."

Growing health consciousness among Europeans is driving an escalating demand for functional foods and dietary supplements offering precise health advantages. With a substantial portion of the European population aged over 50, prone to chronic ailments, there's an increased inclination towards nutraceuticals for both preventive and therapeutic purposes. Ongoing advancements in research and development efforts are resulting in the emergence of innovative excipients characterized by improved functionality, enhanced bioavailability, and targeted nutrient delivery. These advancements are amplifying the effectiveness and attractiveness of nutraceuticals to consumers. Moreover, the surge in the personalization trend within the nutraceutical market is intensifying. Consumers are actively seeking tailored products aligned with their specific needs and preferences, prompting a heightened demand for customizable excipients adaptable to distinct formulations.

The Break-up of Primaries:

By Value Chain: Manufacturers - 80%, Suppliers - 20%

By Designation: CXOs - 44%, Managers - 34%, Executives - 22%

By Region: North America - 35%, Europe - 30%, APAC - 20%, South America - 10%, RoW - 5%

Research Coverage:

The report segments the nutraceutical excipients market based on formulation, functionality, functionality application, product source, end product, and region. In terms of insights, this report has focused on various levels of analyses-the competitive landscape, end-use analysis, and company profiles, which together comprise and discuss views on the emerging & high-growth segments of the nutraceutical excipients market, high-growth regions, countries, government initiatives, drivers, restraints, opportunities, and challenges. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. new product launches, mergers and acquisitions, and recent developments associated with the nutraceutical excipients market. Competitive analysis of upcoming startups in the nutraceutical excipients market ecosystem is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical excipients market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:

  • Analysis of key drivers (Increased focus on preventive care is encouraging investments in products/solutions, which, in turn, is driving the demand for nutraceutical excipients, advancements in nanotechnology equipped with new features to drive the growth of the nutraceutical excipients market, rise in demand for fortified food products due to the increase in health consciousness among consumers, and introduction of mandates on food fortification by government organizations), restraints (Decrease in returns on R&D investments and high costs of clinical trials and registration) opportunities (High use of excipients with multifunctional properties is witnessed as an emerging trend among key players), and challenges (Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumer perception on dietary supplements as pharmaceutical drugs and their false claims).
  • Product Development/Innovation: Detailed insights on, research & development activities, and new product launches in the nutraceutical excipients market
  • Market Development: Comprehensive information about lucrative markets - the report analyses the nutraceutical excipients market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nutraceutical excipients market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players like International Flavors & Fragrances Inc (US), Kerry Group plc (Ireland), Ingredion (US), Sensient Technologies Corporation (US), Associated British Foods plc (UK), BASF SE (Germany), Roquette Freres (France), MEGGLE GmbH & Co. KG (Germany), Cargill, Incorporated (US), Ashland (US), IMCD (Netherlands), Hilmar Cheese Company, Inc (US), Air Liquide (France), Azelis Group (Luxembourg), Biogrund GmbH (Germany), Innophos (US), JRS PHARMA (Germany), Omya AG (Switzerland), Daicel Corporation (Japan), Alsiano A/S (Denmark), Colorcon (US), Fuji Chemical Industries Co., Ltd (Japan), Jigs Chemical (India), Panchamrut Chemicals (India), and GATTEFOSSE (France) among others in the nutraceutical excipients market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
    • 1.1.1 MARKET DEFINITION
  • 1.2 MARKET SCOPE
    • 1.2.1 MARKET SEGMENTATION
    • FIGURE 1 NUTRACEUTICAL EXCIPIENTS MARKET SEGMENTATION
    • 1.2.2 INCLUSIONS & EXCLUSIONS
    • TABLE 1 NUTRACEUTICAL EXCIPIENTS MARKET: INCLUSIONS & EXCLUSIONS
    • 1.2.3 REGIONS COVERED
  • 1.3 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
    • TABLE 2 USD EXCHANGE RATES CONSIDERED, 2019-2022
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
    • 1.6.1 RECESSION IMPACT ANALYSIS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 NUTRACEUTICAL EXCIPIENTS MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key insights from industry experts
      • 2.1.2.3 Breakdown of primary profiles
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 3 BOTTOM-UP APPROACH
    • FIGURE 4 TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 5 DATA TRIANGULATION AND MARKET BREAKUP
  • 2.4 ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS & ASSOCIATED RISKS
  • 2.6 RECESSION IMPACT ANALYSIS
  • 2.7 RECESSION MACRO-INDICATORS
    • FIGURE 6 RECESSION MACRO-INDICATORS
    • FIGURE 7 GLOBAL INFLATION RATE, 2011-2022
    • FIGURE 8 GLOBAL GDP, 2011-2022 (USD TRILLION)
    • FIGURE 9 RECESSION INDICATORS AND THEIR IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
    • FIGURE 10 GLOBAL NUTRACEUTICAL EXCIPIENTS MARKET: EARLIER FORECAST VS. RECESSION FORECAST

3 EXECUTIVE SUMMARY

    • TABLE 3 NUTRACEUTICAL EXCIPIENTS MARKET SNAPSHOT, 2023 VS. 2028
    • FIGURE 11 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028 (USD MILLION)
    • FIGURE 14 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 15 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 16 NUTRACEUTICAL EXCIPIENTS MARKET: REGIONAL SNAPSHOT

4 PREMIUM INSIGHTS

  • 4.1 BRIEF OVERVIEW OF NUTRACEUTICAL EXCIPIENTS MARKET
    • FIGURE 17 HEALTH-CONSCIOUS CONSUMERS, PREVENTIVE HEALTHCARE, AND PERSONALIZED NUTRITION TRENDS TO DRIVE MARKET GROWTH
  • 4.2 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY AND KEY COUNTRY
    • FIGURE 18 COATING AGENTS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET IN 2022
  • 4.3 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION
    • FIGURE 19 NORTH AMERICA TO DOMINATE NUTRACEUTICAL EXCIPIENTS MARKET FROM 2023 TO 2028 (USD MILLION)
  • 4.4 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION
    • FIGURE 20 DRY SEGMENT ESTIMATED TO BE LARGEST THROUGHOUT FORECAST PERIOD (USD MILLION)
  • 4.5 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE
    • FIGURE 21 ORGANIC CHEMICALS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
  • 4.6 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION
    • FIGURE 22 MODIFIED RELEASE TO HOLD LARGEST SHARE IN NUTRACEUTICAL EXCIPIENTS MARKET DURING FORECAST PERIOD (USD MILLION)
  • 4.7 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT
    • FIGURE 23 PROBIOTICS TO BE LARGEST SEGMENT DURING FORECAST PERIOD (USD MILLION)
    • FIGURE 24 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 GLOBAL POPULATION WITNESSING HIGH PREVALENCE OF OBESITY
    • 5.2.2 AGING POPULATION BECOMING MORE AWARE OF BENEFITS OF NUTRACEUTICALS
    • FIGURE 25 US POPULATION AGED 65 AND OLDER, 2000-2060 (MILLION)
  • 5.3 MARKET DYNAMICS
    • FIGURE 26 NUTRACEUTICAL EXCIPIENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.3.1 DRIVERS
      • 5.3.1.1 Increased focus on preventive care to encourage investments in products/solutions
    • FIGURE 27 NUMBER OF AMERICANS WITH CHRONIC CONDITIONS
      • 5.3.1.2 Advancements in nanotechnology equipped with new features relating to nutraceutical excipients
      • 5.3.1.3 Rise in demand for fortified food products due to increased health consciousness
      • 5.3.1.4 Mandates on food fortification by government organizations
    • TABLE 4 PREVALENCE OF THREE MAJOR MICRONUTRIENT DEFICIENCIES, BY REGION
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Decrease in returns on R&D investments and high costs of clinical trials and registration
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Multi-functionalities of excipients aiding in saving costs and processing time
      • 5.3.3.2 Rising awareness of micronutrient deficiencies
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Consumer skepticism associated with nutraceutical products due to rural and semi-urban consumers' perception of dietary supplements as pharmaceutical drugs

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 VALUE CHAIN ANALYSIS
    • FIGURE 28 NUTRACEUTICAL EXCIPIENTS MARKET: VALUE CHAIN ANALYSIS
    • 6.2.1 SOURCING OF RAW MATERIALS
    • 6.2.2 MANUFACTURING
    • 6.2.3 DISTRIBUTION, MARKETING, AND SALES
  • 6.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER'S BUSINESS
    • FIGURE 29 REVENUE SHIFT FOR NUTRACEUTICAL EXCIPIENTS MARKET
  • 6.4 TECHNOLOGY ANALYSIS
    • 6.4.1 FOOD MICROENCAPSULATION
      • 6.4.1.1 Encapsulation of omega-3 to mask odor
    • 6.4.2 INNOVATIVE AND DISRUPTIVE TECH
      • 6.4.2.1 Robotics as key technological trend to lead to innovations
      • 6.4.2.2 3D printing to uplift future of nutraceutical excipients market with high-end products
  • 6.5 PRICING ANALYSIS
    • FIGURE 30 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2019-2022 (USD/TON)
    • TABLE 5 NORTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018-2022 (USD/TON)
    • TABLE 6 EUROPE: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018-2022 (USD/TON)
    • TABLE 7 ASIA PACIFIC: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018-2022 (USD/TON)
    • TABLE 8 SOUTH AMERICA: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018-2022 (USD/TON)
    • TABLE 9 ROW: AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY END PRODUCT, 2018-2022 (USD/TON)
  • 6.6 PATENT ANALYSIS
    • FIGURE 31 LIST OF MAJOR PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS
    • FIGURE 32 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL EXCIPIENTS MARKET, 2012-2022
    • 6.6.1 LIST OF MAJOR PATENTS
  • 6.7 ECOSYSTEM/MARKET MAP
    • 6.7.1 UPSTREAM
      • 6.7.1.1 Excipient Manufacturers
      • 6.7.1.2 Technology Providers
    • 6.7.2 DOWNSTREAM
      • 6.7.2.1 Regulatory Bodies
      • 6.7.2.2 Nutraceutical Manufacturers
    • FIGURE 33 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
    • TABLE 10 NUTRACEUTICAL EXCIPIENTS MARKET: ECOSYSTEM
  • 6.8 TRADE SCENARIO
    • TABLE 11 IMPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
    • TABLE 12 EXPORT DATA OF VITAMINS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
    • TABLE 13 IMPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
    • TABLE 14 EXPORT DATA OF AMINO ACIDS FOR KEY COUNTRIES, 2022 (VALUE & VOLUME)
  • 6.9 KEY CONFERENCES & EVENTS, 2023-2024
    • TABLE 15 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF CONFERENCES & EVENTS, 2023-2024
  • 6.10 TARIFF AND REGULATORY LANDSCAPE
    • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 20 ROW: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.10.2 REGULATORY FRAMEWORK
      • 6.10.2.1 ORGANIZATIONS/REGULATIONS GOVERNING NUTRACEUTICAL EXCIPIENTS MARKET
    • TABLE 21 DEFINITIONS & REGULATIONS FOR NUTRACEUTICAL EXCIPIENTS WORLDWIDE
      • 6.10.2.2 North America
        • 6.10.2.2.1 Canada
        • 6.10.2.2.2 US
        • 6.10.2.2.3 Mexico
      • 6.10.2.3 European Union (EU)
      • 6.10.2.4 Asia Pacific
        • 6.10.2.4.1 Japan
        • 6.10.2.4.2 China
        • 6.10.2.4.3 India
        • 6.10.2.4.4 Australia & New Zealand
      • 6.10.2.5 Rest of the World (RoW)
        • 6.10.2.5.1 Israel
        • 6.10.2.5.2 Brazil
      • 6.10.2.6 Probiotics
        • 6.10.2.6.1 Introduction
        • 6.10.2.6.2 National/International bodies for safety standards and regulations
    • TABLE 22 DEFINITIONS & REGULATIONS FOR NUTRACEUTICALS WORLDWIDE
        • 6.10.2.6.3 Codex alimentarius commission (CAC)
        • 6.10.2.6.4 North America: regulatory environment analysis
          • 6.10.2.6.4.1 US
          • 6.10.2.6.4.2 Canada
        • 6.10.2.6.5 Asia Pacific: Regulatory environment analysis
          • 6.10.2.6.5.1 Japan
          • 6.10.2.6.5.2 India
        • 6.10.2.6.6 South America: Regulatory Environment Analysis
          • 6.10.2.6.6.1 Brazil
      • 6.10.2.7 PREBIOTICS
        • 6.10.2.7.1 Introduction
        • 6.10.2.7.2 Asia Pacific
          • 6.10.2.7.2.1 Japan
          • 6.10.2.7.2.2 Australia & New Zealand
          • 6.10.2.7.2.3 South Korea
          • 6.10.2.7.2.4 India
    • TABLE 23 SCHEDULE - XI OF FOOD SAFETY AND STANDARDS REGULATIONS, 2015, FOR LIST OF APPROVED PREBIOTIC EXCIPIENTS
        • 6.10.2.7.3 North America
          • 6.10.2.7.3.1 US
          • 6.10.2.7.3.2 Canada
    • TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES & THEIR SOURCES
        • 6.10.2.7.4 European Union
  • 6.11 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 25 PORTER'S FIVE FORCES IMPACT ON NUTRACEUTICAL EXCIPIENTS MARKET
    • 6.11.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.11.2 BARGAINING POWER OF SUPPLIERS
    • 6.11.3 BARGAINING POWER OF BUYERS
    • 6.11.4 THREAT OF SUBSTITUTES
    • 6.11.5 THREAT OF NEW ENTRANTS
  • 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 TYPES
    • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 PRODUCT SOURCES (%)
    • 6.12.2 BUYING CRITERIA
    • TABLE 27 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
    • FIGURE 35 KEY CRITERIA FOR SELECTING SUPPLIER/VENDOR FOR TOP 3 TYPES
  • 6.13 CASE STUDY ANALYSIS
    • 6.13.1 USE CASE 1: FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
    • 6.13.2 USE CASE 2: EXCIPIENTS OF CHOICE FOR TASTE MASKING TECHNOLOGY WITH HOT MELT EXTRUSION

7 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE

  • 7.1 INTRODUCTION
    • FIGURE 36 NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023 VS. 2028 (USD MILLION)
  • 7.2 ORGANIC CHEMICALS
    • TABLE 28 ORGANIC EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 29 ORGANIC EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 30 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2018-2022 (USD MILLION)
    • TABLE 31 ORGANIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY TYPE, 2023-2028 (USD MILLION)
    • 7.2.1 OLEOCHEMICALS
    • TABLE 32 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 33 OLEOCHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
      • 7.2.1.1 Fatty alcohols
        • 7.2.1.1.1 Need for enhancing texture and creaminess likely to propel demand
      • 7.2.1.2 Mineral stearates
        • 7.2.1.2.1 Mineral stearates to reduce friction and avoid equipment clogging during manufacturing of nutraceuticals
      • 7.2.1.3 Glycerin
        • 7.2.1.3.1 Glycerin to help improve smoothness and lubrication process
      • 7.2.1.4 Other oleochemicals
    • 7.2.2 CARBOHYDRATES
    • TABLE 34 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 35 CARBOHYDRATES: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
      • 7.2.2.1 Sugars
    • TABLE 36 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 37 SUGARS: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
        • 7.2.2.1.1 Actual sugars
          • 7.2.2.1.1.1 Rising diabetic population to fuel need for low-glycemic index alternatives like xylitol and isomaltulose
        • 7.2.2.1.2 Sugar alcohols
          • 7.2.2.1.2.1 Various advantageous and unique properties of sugar alcohols to make them attractive option
        • 7.2.2.1.3 Artificial sweeteners
          • 7.2.2.1.3.1 Emerging trends in utilization of natural sweeteners in nutraceutical products to drive demand
      • 7.2.2.2 Cellulose
    • TABLE 38 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 39 CELLULOSE: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
        • 7.2.2.2.1 Microcrystalline cellulose
          • 7.2.2.2.1.1 Rising nutraceutical trend to bolster microcrystalline cellulose demand for superior tablet integrity
        • 7.2.2.2.2 Cellulose ethers
          • 7.2.2.2.2.1 Cellulose ethers help streamline nutraceutical rheology
        • 7.2.2.2.3 CMC & croscarmellose sodium
          • 7.2.2.2.3.1 Enhanced mouthfeel and fast-acting properties to help propel market growth
        • 7.2.2.2.4 Cellulose esters
          • 7.2.2.2.4.1 Rising demand for cellulose esters to provide technical edge in nutraceuticals
      • 7.2.2.3 Starch
    • TABLE 40 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 41 STARCH: NUTRACEUTICAL EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
        • 7.2.2.3.1 Modified starch
          • 7.2.2.3.1.1 Technical advancements to fuel modified starch demand in nutraceuticals excipients industry
        • 7.2.2.3.2 Dried starch
          • 7.2.2.3.2.1 Capabilities such as disintegration enhancement and bulking effects to drive market
        • 7.2.2.3.3 Converted starch
          • 7.2.2.3.3.1 Properties such as increased solubility to boost nutrient absorption
    • 7.2.3 PETROCHEMICALS
    • TABLE 42 PETROCHEMICALS EXCIPIENTS MARKET, BY, SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 43 PETROCHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
      • 7.2.3.1 Glycols
        • 7.2.3.1.1 Humectant & solvent properties to drive demand
      • 7.2.3.2 Povidones
        • 7.2.3.2.1 Film-forming function to provide controlled release of active ingredients
      • 7.2.3.3 Mineral hydrocarbons
        • 7.2.3.3.1 Properties such as anti-foaming & lubrication to help in nutraceutical manufacturing
      • 7.2.3.4 Acrylic polymers
        • 7.2.3.4.1 Diverse functions of acrylic polymers in nutraceuticals to propel growth
      • 7.2.3.5 Other petrochemical excipients
    • 7.2.4 PROTEINS
      • 7.2.4.1 Expanding utilization of proteins as carriers for microparticles and nanoparticles to propel market growth
    • 7.2.5 OTHER ORGANIC CHEMICALS
  • 7.3 INORGANIC CHEMICALS
    • TABLE 44 INORGANIC EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 45 INORGANIC EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 46 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2018-2022 (USD MILLION)
    • TABLE 47 INORGANIC CHEMICALS EXCIPIENTS MARKET, BY SUBTYPE, 2023-2028 (USD MILLION)
    • 7.3.1 CALCIUM PHOSPHATE
      • 7.3.1.1 Nutraceutical production to be optimized by utilizing GMO-free calcium phosphates as GRAS excipients
    • 7.3.2 METAL OXIDES
      • 7.3.2.1 Metal oxides to help meet rising demand for iron-enriched nutraceuticals
    • 7.3.3 HALITES
      • 7.3.3.1 Halites to ensure taste improvement and salting-out techniques
    • 7.3.4 CALCIUM CARBONATE
      • 7.3.4.1 Focus on R&D of calcium carbonate to help launch new products
    • 7.3.5 CALCIUM SULFATE
      • 7.3.5.1 Improved flowability to drive demand for calcium sulfate
    • 7.3.6 OTHER INORGANIC CHEMICALS
  • 7.4 OTHER CHEMICALS
    • TABLE 48 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 49 OTHER CHEMICALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)

8 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT

  • 8.1 INTRODUCTION
    • TABLE 50 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 51 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • FIGURE 37 NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023 VS. 2028
  • 8.2 PROBIOTICS
    • 8.2.1 INCREASING INCLINATION OF CONSUMERS TOWARD IMMUNITY-ENHANCING PRODUCTS POST-COVID-19 TO DRIVE MARKET GROWTH
    • TABLE 52 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 53 PROBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.3 PREBIOTICS
    • 8.3.1 INCREASE IN DIGESTIVE ISSUES AMONG CONSUMERS RESULTING IN ACIDITY AND INFLAMMATORY ISSUES, TO ENCOURAGE CONSUMPTION OF PREBIOTICS AS PREVENTIVE MEASURE
    • TABLE 54 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 55 PREBIOTICS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.4 PROTEINS & AMINO ACIDS
    • 8.4.1 INCREASED POPULARITY OF PROTEINS AND AMINO ACIDS AMONG YOUTH TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
    • TABLE 56 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 57 PROTEINS & AMINO ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.5 VITAMINS
    • 8.5.1 PREVALENCE OF VITAMIN DEFICIENCIES AMONG CONSUMERS TO DRIVE MARKET GROWTH FOR NUTRACEUTICAL EXCIPIENTS
    • TABLE 58 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 59 VITAMINS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 60 LIST OF NUTRIENTS AND THEIR RELEVANCE
  • 8.6 MINERALS
    • 8.6.1 BENEFITS OFFERED FOR OPTIMAL FUNCTIONING OF BRAIN AND HEART TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
    • TABLE 61 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 62 MINERALS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.7 OMEGA-3 FATTY ACIDS
    • 8.7.1 INCREASE IN HEART DISEASES TO DRIVE DEMAND FOR OMEGA-3 FATTY ACIDS SUPPLEMENTS
    • TABLE 63 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 64 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 8.8 OTHER END PRODUCTS
    • TABLE 65 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 66 OTHER END PRODUCTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)

9 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION

  • 9.1 INTRODUCTION
    • TABLE 67 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 68 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • FIGURE 38 NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023 VS. 2028
  • 9.2 DRY
    • TABLE 69 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 70 DRY: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
    • 9.2.1 TABLETS
      • 9.2.1.1 Easy to carry and portable nature to make them attractive option
    • 9.2.2 CAPSULES
      • 9.2.2.1 Quick-dissolving capsule shells for targeted absorption to be ideal for nutraceuticals designed to act in specific areas of digestive tract
  • 9.3 LIQUID
    • 9.3.1 POTENTIAL GROWTH OPPORTUNITIES FOR LIQUID NUTRACEUTICAL EXCIPIENTS DUE TO INNOVATIONS IN FORMULATIONS TO DRIVE GROWTH
    • TABLE 71 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 72 LIQUID: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 9.4 OTHER FORMULATIONS
    • TABLE 73 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 74 OTHER FORMULATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)

10 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY

  • 10.1 INTRODUCTION
    • TABLE 75 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 76 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • FIGURE 39 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023 VS. 2028
  • 10.2 BINDERS
    • 10.2.1 INCREASED ACCEPTABILITY AND USE OF BINDING AGENTS IN PRODUCTS TO DRIVE GROWTH OF NUTRACEUTICAL EXCIPIENTS MARKET
    • TABLE 77 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 78 BINDERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.3 FILLERS & DILUENTS
    • 10.3.1 USE OF ACTIVE INGREDIENTS IN NUTRACEUTICAL PRODUCTS TO ENCOURAGE USE OF FILLERS AND DILUENTS AS EXCIPIENTS
    • TABLE 79 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 80 FILLERS & DILUENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.4 DISINTEGRANTS
    • 10.4.1 HIGH CONSUMPTION OF DIETARY SUPPLEMENTS IN FORM OF ORAL DOSAGES OR TABLETS TO DRIVE GROWTH OF DISINTEGRANTS SEGMENT
    • TABLE 81 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 82 DISINTEGRANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.5 COATING AGENTS
    • 10.5.1 PROTECTION FROM MOISTURE AND BACTERIA TO DRIVE DEMAND
    • TABLE 83 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 84 COATING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.6 FLAVORING AGENTS & SWEETENERS
    • 10.6.1 INCREASE IN NEED FOR MASKING STRONG AND UNAPPEALING FLAVORS TO DRIVE GROWTH OF SEGMENT
    • TABLE 85 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 86 FLAVORING AGENTS & SWEETENERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.7 PRESERVATIVES
    • 10.7.1 INHIBITION OF MICROBIAL GROWTH AND MAINTAINING PRODUCT QUALITY AND SAFETY TO DRIVE DEMAND FOR PRESERVATIVES
    • TABLE 87 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 88 PRESERVATIVES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.8 LUBRICANTS & GLIDANTS
    • 10.8.1 INCREASE IN NEED FOR REDUCING FRICTION AND KEEPING FORMULATION INTACT DURING PRODUCTION PROCESS TO DRIVE GROWTH OF SEGMENT
    • TABLE 89 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 90 LUBRICANTS & GLIDANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.9 SUSPENDING & VISCOSITY AGENTS
    • 10.9.1 PREVENTING SETTLING TO HELP MAINTAIN HOMOGENEITY AND STABILITY OF PRODUCT
    • TABLE 91 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 92 SUSPENDING & VISCOSITY AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.10 COLORANTS
    • 10.10.1 NEED FOR VISUAL APPEAL AND PRODUCT DIFFERENTIATION TO FUEL DEMAND FOR COLORANTS
    • TABLE 93 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 94 COLORANTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.11 EMULSIFYING AGENTS
    • 10.11.1 NEED FOR REDUCING SURFACE TENSION BETWEEN DIFFERENT COMPONENTS TO DRIVE DEMAND FOR EMULSIFYING AGENTS
    • TABLE 95 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 96 EMULSIFYING AGENTS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 10.12 OTHER FUNCTIONALITIES
    • TABLE 97 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 98 OTHER FUNCTIONALITIES: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)

11 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION

  • 11.1 INTRODUCTION
    • TABLE 99 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 100 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATI0N, 2023-2028 (USD MILLION)
    • FIGURE 40 NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023 VS. 2028
  • 11.2 TASTE MASKING
    • 11.2.1 CREATING DIFFERENTIATION TO BE KEY IN THIS COMPETITIVE MARKET
    • TABLE 101 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 102 TASTE MASKING: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.3 STABILIZERS
    • 11.3.1 MAINTAINING DESIRABLE PROPERTIES UNTIL CONSUMPTION TO DRIVE DEMAND FOR STABILIZERS
    • TABLE 103 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 104 STABILIZERS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.4 MODIFIED RELEASE
    • 11.4.1 NEED FOR SLOWER AND STEADIER RELEASE OF COMPOUNDS TO PROPEL GROWTH OF MODIFIED-RELEASE APPLICATION IN NUTRACEUTICAL EXCIPIENTS MARKET
    • TABLE 105 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 106 MODIFIED RELEASE: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.5 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT
    • 11.5.1 CHALLENGES RELATED TO POOR SOLUBILITY AND LIMITED ABSORPTION OF BIOACTIVE COMPOUNDS TO DRIVE DEMAND
    • TABLE 107 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 108 SOLUBILITY & BIOAVAILABILITY ENHANCEMENT: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 11.6 OTHER FUNCTIONALITY APPLICATIONS
    • TABLE 109 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 110 OTHER FUNCTIONALITY APPLICATIONS: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)

12 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION

  • 12.1 INTRODUCTION
    • FIGURE 41 NORTH AMERICA TO BE LARGEST MARKET THROUGHOUT FORECAST PERIOD
    • FIGURE 42 CHINA, INDIA, AND SOUTH KOREA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
    • TABLE 111 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 112 NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
  • 12.2 NORTH AMERICA
    • FIGURE 43 NORTH AMERICA: MARKET SNAPSHOT
    • 12.2.1 RECESSION IMPACT ANALYSIS
    • FIGURE 44 NORTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 113 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 114 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 115 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018-2022 (USD MILLION)
    • TABLE 116 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023-2028 (USD MILLION)
    • TABLE 117 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 118 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • TABLE 119 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 120 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • TABLE 121 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 122 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • TABLE 123 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 124 NORTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2028 (USD MILLION)
    • 12.2.2 US
      • 12.2.2.1 High concentration of key players, various nutrition awareness programs, and increase in preventive healthcare trends in US
    • TABLE 125 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 126 US: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.2.3 CANADA
      • 12.2.3.1 Demand for quality and cost-competition: Two key factors for manufacturers to consider in Canada
    • TABLE 127 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 128 CANADA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.2.4 MEXICO
      • 12.2.4.1 Increase in foreign direct investments and rise in awareness regarding healthier lifestyles associated with dietary supplements
    • TABLE 129 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 130 MEXICO: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
  • 12.3 EUROPE
    • 12.3.1 RECESSION IMPACT ANALYSIS
    • FIGURE 45 EUROPEAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 131 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 132 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 133 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018-2022 (USD MILLION)
    • TABLE 134 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023-2028 (USD MILLION)
    • TABLE 135 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 136 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • TABLE 137 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 138 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • TABLE 139 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 140 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • TABLE 141 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 142 EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2028 (USD MILLION)
    • 12.3.2 GERMANY
      • 12.3.2.1 Demand for nutraceutical excipients likely to increase to serve health-conscious consumers
    • TABLE 143 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 144 GERMANY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.3.3 FRANCE
      • 12.3.3.1 Innovations in product formulations to cater to increased consumer demands
    • TABLE 145 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 146 FRANCE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.3.4 UK
      • 12.3.4.1 Growth of functional/fortified food & beverage industry in UK to drive demand for nutraceutical excipients
    • TABLE 147 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 148 UK: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.3.5 ITALY
      • 12.3.5.1 Growing trend of online OTC and food supplement purchases in Italy
    • TABLE 149 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 150 ITALY: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.3.6 SPAIN
      • 12.3.6.1 Growth of food supplements, sports nutrition, and healthcare care markets likely to create favorable environment for nutraceutical excipients
    • TABLE 151 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 152 SPAIN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.3.7 REST OF EUROPE
    • TABLE 153 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 154 REST OF EUROPE: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
  • 12.4 ASIA PACIFIC
    • FIGURE 46 ASIA PACIFIC: MARKET SNAPSHOT
    • 12.4.1 RECESSION IMPACT ANALYSIS
    • FIGURE 47 ASIA PACIFIC NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 155 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 156 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 157 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018-2022 (USD MILLION)
    • TABLE 158 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023-2028 (USD MILLION)
    • TABLE 159 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 160 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • TABLE 161 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 162 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • TABLE 163 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 164 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • TABLE 165 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 166 ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2028 (USD MILLION)
    • 12.4.2 CHINA
      • 12.4.2.1 Rise in preference for nutraceutical products and innovations in dietary supplement formulations and fortified food products
    • TABLE 167 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 168 CHINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.4.3 JAPAN
      • 12.4.3.1 Manufacturers should think beyond pills & innovation to tap this growing market in Japan
    • TABLE 169 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 170 JAPAN: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.4.4 INDIA
      • 12.4.4.1 Government policies and importance of nutraceuticals in daily life
    • TABLE 171 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 172 INDIA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.4.5 SOUTH KOREA
      • 12.4.5.1 Rapid growth of supplements industry in South Korea
    • TABLE 173 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 174 SOUTH KOREA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.4.6 REST OF ASIA PACIFIC
    • TABLE 175 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 176 REST OF ASIA PACIFIC: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
  • 12.5 SOUTH AMERICA
    • 12.5.1 RECESSION IMPACT ANALYSIS
    • FIGURE 48 SOUTH AMERICAN NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 177 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2018-2022 (USD MILLION)
    • TABLE 178 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY COUNTRY, 2023-2028 (USD MILLION)
    • TABLE 179 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018-2022 (USD MILLION)
    • TABLE 180 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023-2028 (USD MILLION)
    • TABLE 181 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 182 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • TABLE 183 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 184 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • TABLE 185 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 186 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • TABLE 187 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 188 SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2028 (USD MILLION)
    • 12.5.2 BRAZIL
      • 12.5.2.1 Growth in awareness regarding benefits of functional foods and rise in aging population in Brazil
    • TABLE 189 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 190 BRAZIL: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.5.3 ARGENTINA
      • 12.5.3.1 Country's focus on prevention healthcare system to be positive sign for nutraceutical excipients market
    • TABLE 191 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 192 ARGENTINA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.5.4 REST OF SOUTH AMERICA
    • TABLE 193 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 194 REST OF SOUTH AMERICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
  • 12.6 REST OF THE WORLD (ROW)
    • 12.6.1 RECESSION IMPACT ANALYSIS
    • FIGURE 49 ROW NUTRACEUTICAL EXCIPIENTS MARKET: RECESSION IMPACT ANALYSIS
    • TABLE 195 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2018-2022 (USD MILLION)
    • TABLE 196 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY REGION, 2023-2028 (USD MILLION)
    • TABLE 197 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2018-2022 (USD MILLION)
    • TABLE 198 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY PRODUCT SOURCE, 2023-2028 (USD MILLION)
    • TABLE 199 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 200 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • TABLE 201 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2018-2022 (USD MILLION)
    • TABLE 202 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FORMULATION, 2023-2028 (USD MILLION)
    • TABLE 203 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2018-2022 (USD MILLION)
    • TABLE 204 ROW NUTRACEUTICAL EXCIPIENTS MARKET, BY END PRODUCT, 2023-2028 (USD MILLION)
    • TABLE 205 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2018-2022 (USD MILLION)
    • TABLE 206 ROW: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY APPLICATION, 2023-2028 (USD MILLION)
    • 12.6.2 MIDDLE EAST
      • 12.6.2.1 Rise in obesity and other health-related concerns in Middle East
    • TABLE 207 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 208 MIDDLE EAST: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)
    • 12.6.3 AFRICA
      • 12.6.3.1 Intra-African trade policies and investments by global nutraceutical players
    • TABLE 209 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2018-2022 (USD MILLION)
    • TABLE 210 AFRICA: NUTRACEUTICAL EXCIPIENTS MARKET, BY FUNCTIONALITY, 2023-2028 (USD MILLION)

13 COMPETITIVE LANDSCAPE

  • 13.1 OVERVIEW
  • 13.2 MARKET SHARE ANALYSIS
    • TABLE 211 NUTRACEUTICAL EXCIPIENTS MARKET: DEGREE OF COMPETITION, 2022
  • 13.3 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • TABLE 212 STRATEGIES ADOPTED BY KEY PLAYERS
  • 13.4 REVENUE ANALYSIS
    • FIGURE 50 HISTORICAL REVENUE ANALYSIS OF KEY PLAYERS, 2020-2022 (USD BILLION)
  • 13.5 KEY PLAYER ANNUAL REVENUE VS. GROWTH
    • FIGURE 51 ANNUAL REVENUE, 2022 (USD BILLION) VS. REVENUE GROWTH, 2020-2022 (%)
  • 13.6 KEY PLAYERS' EBIT/EBITDA
    • FIGURE 52 EBITDA, 2022 (USD BILLION)
  • 13.7 GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS
    • FIGURE 53 NUTRACEUTICAL EXCIPIENTS MARKET: GLOBAL SNAPSHOT OF KEY MARKET PARTICIPANTS, 2022
  • 13.8 COMPANY EVALUATION MATRIX (KEY PLAYERS)
    • 13.8.1 STARS
    • 13.8.2 EMERGING LEADERS
    • 13.8.3 PERVASIVE PLAYERS
    • 13.8.4 PARTICIPANTS
    • FIGURE 54 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2022
    • 13.8.5 COMPANY FOOTPRINT
    • TABLE 213 COMPANY FOOTPRINT, BY FUNCTIONALITY
    • TABLE 214 COMPANY FOOTPRINT, BY PRODUCT SOURCE
    • TABLE 215 COMPANY FOOTPRINT, BY REGION
    • TABLE 216 OVERALL COMPANY FOOTPRINT
  • 13.9 STARTUP/SME EVALUATION MATRIX
    • 13.9.1 PROGRESSIVE COMPANIES
    • 13.9.2 RESPONSIVE COMPANIES
    • 13.9.3 DYNAMIC COMPANIES
    • 13.9.4 STARTING BLOCKS
    • FIGURE 55 STARTUP/SME EVALUATION MATRIX, 2022
    • 13.9.5 COMPETITIVE BENCHMARKING
    • TABLE 217 NUTRACEUTICAL EXCIPIENTS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 218 NUTRACEUTICAL EXCIPIENTS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
    • TABLE 219 COMPANY FOOTPRINT, BY FUNCTIONALITY (STARTUPS)
  • 13.10 COMPETITIVE SCENARIO
    • 13.10.1 NEW PRODUCT LAUNCHES
    • TABLE 220 NUTRACEUTICAL EXCIPIENTS MARKET: NEW PRODUCT LAUNCHES, 2019-2023
    • 13.10.2 DEALS
    • TABLE 221 NUTRACEUTICAL EXCIPIENTS MARKET: DEALS, 2019-2023
    • 13.10.3 OTHERS
    • TABLE 222 NUTRACEUTICAL EXCIPIENTS MARKET: OTHERS, 2019-2023

14 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, MnM View Right to win, Strategic choices made, Weaknesses and competitive threats) **
  • 14.1 KEY PLAYERS
    • 14.1.1 INTERNATIONAL FLAVORS & FRAGRANCES INC
    • TABLE 223 INTERNATIONAL FLAVORS & FRAGRANCES INC: BUSINESS OVERVIEW
    • FIGURE 56 INTERNATIONAL FLAVORS & FRAGRANCES INC: COMPANY SNAPSHOT
    • TABLE 224 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 225 INTERNATIONAL FLAVORS & FRAGRANCES INC: PRODUCT LAUNCHES
    • TABLE 226 INTERNATIONAL FLAVORS & FRAGRANCES INC: DEALS
    • 14.1.2 KERRY GROUP PLC
    • TABLE 227 KERRY GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 57 KERRY GROUP PLC: COMPANY SNAPSHOT
    • TABLE 228 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 229 KERRY GROUP PLC: DEALS
    • 14.1.3 INGREDION
    • TABLE 230 INGREDION: BUSINESS OVERVIEW
    • FIGURE 58 INGREDION: COMPANY SNAPSHOT
    • TABLE 231 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 232 INGREDION: DEALS
    • 14.1.4 SENSIENT TECHNOLOGIES CORPORATION
    • TABLE 233 SENSIENT TECHNOLOGIES CORPORATION: BUSINESS OVERVIEW
    • FIGURE 59 SENSIENT TECHNOLOGIES CORPORATION: COMPANY SNAPSHOT
    • TABLE 234 SENSIENT TECHNOLOGIES CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 235 SENSIENT TECHNOLOGIES CORPORATION: DEALS
    • 14.1.5 ASSOCIATED BRITISH FOODS PLC
    • TABLE 236 ASSOCIATED BRITISH FOODS PLC: BUSINESS OVERVIEW
    • FIGURE 60 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
    • TABLE 237 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 238 ASSOCIATED BRITISH FOODS PLC: PRODUCT LAUNCHES
    • 14.1.6 BASF SE
    • TABLE 239 BASF SE: BUSINESS OVERVIEW
    • FIGURE 61 BASF SE: COMPANY SNAPSHOT
    • TABLE 240 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 241 BASF SE: DEALS
    • TABLE 242 BASF SE: OTHERS
    • 14.1.7 ROQUETTE FRERES
    • TABLE 243 ROQUETTE FRERES: BUSINESS OVERVIEW
    • TABLE 244 ROQUETTE FRERES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 245 ROQUETTE FRERES: PRODUCT LAUNCHES
    • TABLE 246 ROQUETTE FRERES: DEALS
    • TABLE 247 ROQUETTE FRERES: OTHERS
    • 14.1.8 MEGGLE GROUP GMBH
    • TABLE 248 MEGGLE GROUP GMBH: BUSINESS OVERVIEW
    • TABLE 249 MEGGLE GROUP GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.9 CARGILL, INCORPORATED
    • TABLE 250 CARGILL, INCORPORATED: BUSINESS OVERVIEW
    • FIGURE 62 CARGILL, INCORPORATED: COMPANY SNAPSHOT
    • TABLE 251 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 252 CARGILL, INCORPORATED: DEALS
    • TABLE 253 CARGILL, INCORPORATED: OTHERS
    • 14.1.10 ASHLAND
    • TABLE 254 ASHLAND: BUSINESS OVERVIEW
    • FIGURE 63 ASHLAND: COMPANY SNAPSHOT
    • TABLE 255 ASHLAND: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 256 ASHLAND: PRODUCT LAUNCHES
    • TABLE 257 ASHLAND: OTHERS
    • 14.1.11 AZELIS GROUP
    • TABLE 258 AZELIS GROUP: BUSINESS OVERVIEW
    • FIGURE 64 AZELIS GROUP: COMPANY SNAPSHOT
    • TABLE 259 AZELIS GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 260 AZELIS GROUP: DEALS
    • TABLE 261 AZELIS GROUP: OTHERS
    • 14.1.12 IMCD
    • TABLE 262 IMCD: BUSINESS OVERVIEW
    • FIGURE 65 IMCD: COMPANY SNAPSHOT
    • TABLE 263 IMCD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 264 IMCD: DEALS
    • TABLE 265 IMCD: OTHERS
    • 14.1.13 HILMAR CHEESE COMPANY, INC.
    • TABLE 266 HILMAR CHEESE COMPANY, INC: BUSINESS OVERVIEW
    • TABLE 267 HILMAR CHEESE COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.1.14 SEPPIC
    • TABLE 268 SEPPIC: BUSINESS OVERVIEW
    • TABLE 269 SEPPIC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 270 SEPPIC: PRODUCT LAUNCHES
    • 14.1.15 BIOGRUND GMBH
    • TABLE 271 BIOGRUND GMBH: BUSINESS OVERVIEW
    • TABLE 272 BIOGRUND GMBH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • 14.2 OTHER PLAYERS
    • 14.2.1 INNOPHOS
    • TABLE 273 INNOPHOS: BUSINESS OVERVIEW
    • TABLE 274 INNOPHOS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 275 INNOPHOS: PRODUCT LAUNCHES
    • 14.2.2 DAICEL CORPORATION
    • TABLE 276 DAICEL CORPORATION: BUSINESS OVERVIEW
    • FIGURE 66 DAICEL CORPORATION: COMPANY SNAPSHOT
    • TABLE 277 DAICEL CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.2.3 ALSIANO A/S
    • TABLE 278 ALSIANO A/S: BUSINESS OVERVIEW
    • TABLE 279 ALSIANO A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • 14.2.4 JRS PHARMA
    • TABLE 280 JRS PHARMA: BUSINESS OVERVIEW
    • TABLE 281 JRS PHARMA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 282 JRS PHARMA: OTHERS
    • 14.2.5 COLORCON
    • TABLE 283 COLORCON: BUSINESS OVERVIEW
    • TABLE 284 COLORCON: PRODUCTS/SOLUTIONS/SERVICES OFFERED
    • TABLE 285 COLORCON: PRODUCT LAUNCHES
    • TABLE 286 COLORCON: DEALS
    • TABLE 287 COLORCON: OTHERS
    • 14.2.6 PANCHAMRUT CHEMICALS
    • TABLE 288 PANCHAMRUT CHEMICALS: BUSINESS OVERVIEW
    • 14.2.7 OMYA
    • TABLE 289 OMYA: BUSINESS OVERVIEW
    • 14.2.8 GATTEFOSSE
    • TABLE 290 GATTEFOSSE: BUSINESS OVERVIEW
    • 14.2.9 FUJI CHEMICAL INDUSTRIES CO., LTD
    • TABLE 291 FUJI CHEMICAL INDUSTRIES CO., LTD: BUSINESS OVERVIEW
    • 14.2.10 JIGS CHEMICAL
    • TABLE 292 JIGS CHEMICAL: BUSINESS OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, MnM View, Right to win, Strategic choices made, Weaknesses and competitive threats might not be captured in case of unlisted companies.

15 ADJACENT & RELATED MARKETS

  • 15.1 INTRODUCTION
  • 15.2 LIMITATIONS
  • 15.3 FUNCTIONAL FOOD INGREDIENTS MARKET
    • 15.3.1 MARKET DEFINITION
    • 15.3.2 MARKET OVERVIEW
    • 15.3.3 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE
      • 15.3.3.1 Introduction
    • TABLE 293 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 294 FUNCTIONAL FOOD INGREDIENTS MARKET, BY TYPE, 2021-2026 (USD MILLION)
  • 15.4 NUTRACEUTICAL INGREDIENTS MARKET
    • 15.4.1 MARKET DEFINITION
    • 15.4.2 MARKET OVERVIEW
    • 15.4.3 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE
      • 15.4.3.1 Introduction
    • TABLE 295 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (USD MILLION)
    • TABLE 296 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (USD MILLION)
    • TABLE 297 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2017-2021 (KT)
    • TABLE 298 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2022-2027 (KT)

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS